GlassScriptPhysician profile
Desiree Riley
NPI 1881259703
$10,993.00
in general payments reported to CMS, 2019-2025
25 companies · $1,919 in 2025
The $1,919 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,265 · 2022: $2,231 · 2023: $2,019 · 2024: $3,558 · 2025: $1,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,801 · Travel and Lodging: $655 · Education: $40.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,801.30 |
| Travel and Lodging | $655.30 |
| Education | $40.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,335.49 | 2021-2024 | Senza |
| Boston Scientific Corporation | $3,475.39 | 2021-2025 | General - Pain Management, Intracept, General - Therapies |
| Curonix LLC | $801.20 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $522.54 | 2025 | Senza, Omnia |
| Si-Bone, INC. | $368.51 | 2021-2022 | |
| Stimwave Technologies Incorporated | $255.47 | 2021-2022 | |
| Spr Therapeutics, INC | $204.33 | 2022-2024 | Sprint Pns System |
| Painteq LLC | $137.87 | 2022-2023 | Painteq |
| Abbott Laboratories | $135.62 | 2021-2022 | |
| Amgen INC. | $129.05 | 2021 | |
| Collegium Pharmaceutical, INC. | $105.64 | 2021-2022 | |
| Medtronic, INC. | $94.13 | 2022 | |
| Radius Health, INC. | $75.13 | 2021-2023 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $59.21 | 2025 | |
| Merz Pharmaceuticals, LLC | $53.27 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $40.52 | 2021-2022 | |
| Bioventus LLC | $35.96 | 2023 | Stimrouter Implantable Kit |
| Acelrx Pharmaceuticals, INC. | $32.20 | 2021 | |
| Virtus Pharmaceuticals LLC | $25.92 | 2021 | |
| Averitas Pharma INC. | $23.73 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $19.49 | 2021 | |
| Medline Industries LP | $18.47 | 2023 | |
| Saluda Medical Americas, INC. | $15.12 | 2023 | Evoke Scs |
| Medacta USA, INC. | $14.94 | 2024 | |
| Arbor Pharmaceuticals, INC. | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiree Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.